FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
News|Articles|May 26, 2020
Contec Launches Sustainable Wipe for the Cleanroom Industry
Author(s)Pharmaceutical Technology Editors
All ReFIBE wipes are laser-cut with heatsealed edges and cleanroom laundered to lessen the amount of releasable particles and fibers.
Advertisement
On May 20, 2020, Contec launched ReFIBE, a sustainable polyester wipe for the cleanroom industry.
According to a company press release, the wipes are made from recycled post-consumer plastic bottles that are chopped into flake and cleaned, then melted, filtered, and formed into chips. The chips are then melted and made into yarn and knitted into each wipe.
All ReFIBE wipes are laser-cut with heatsealed edges and cleanroom laundered to lessen the amount of releasable particles and fibers, the press release said. The wipes are available in two sizes, 9 in. x 9 in. and 12 in. x 12 in.
Source:
Advertisement
Related to this article
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Jaenisch, Muraru, and Pandey discuss new skills for QC and regulatory teams, plus patient trust, as new approach methodologies reshape pharma.
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
OpenAI acquired Orchestra Bio to pair AI agents that track drug development timelines with its Rosalind life sciences tools, raising oversight questions for pharma teams.
Ravi Kiran Kaja, PhD, explains how USP’s industry-wide initiative aims to build confidence in trace-level extractables and leachables results.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
2
FDA Approves Bepirovirsen: Why Oligonucleotide CDMOs Should Take Note
3
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
4
Nitrosamine Problems and Industry Solutions: PharmTech Explained
5